.png){kind=icon}
.png){kind=icon}
Return
Echinomycin biosynthesis
.png){kind=icon}
PRE
AI
DOI：10.1016/j.cbpa.2013.06.022.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Echinomycin is an antitumor antibiotic secondary metabolite isolated from streptomycetes, whose core structure is biosynthesized by nonribosomal peptide synthetase (NAPS). The echinomycin biosynthetic pathway was successfully reconstituted in Escherichia coli. NRPS often contains a thioesterase domain at its C terminus for cyclorelease of the elongating peptide chain. Those thioesterase domains were shown to exhibit significant substrate tolerance. More recently, an oxidoreductase Ecm17, which forms the disulfide bridge in triostin A, was characterized. Surprisingly, an unrelated disulfide-forming enzyme GliT for gliotoxin biosynthesis was also able to catalyze the same reaction, providing another example of broad substrate specificity in secondary metabolite biosynthetic enzymes. Those promiscuous catalysts can be a valuable tool in generating diversity in natural products analogs we can produce heterologously.
Keywords:
NONRIBOSOMAL PEPTIDE SYNTHETASES
FATTY-ACID SYNTHASE
ESCHERICHIA-COLI
NATURAL-PRODUCT
MYCOBACTERIUM-TUBERCULOSIS
HETEROLOGOUS HOST
BOND FORMATION
TRIOSTIN-A
THIOESTERASE
PATHWAY
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
6.1
Papers:
3.1K
Citations:
1.1W